Laurie brings over 20 years of experience and roles ranging from clinical study coordinator, to clinical research associate (CRA), followed by progression to Operations Head and Franchise Leader. Her therapeutically aligned operational experience includes leading large Phase III global clinical trials as well as small scale early phase clinical trials testing small molecule and large molecule therapies.
She was the Program Director for global Phase III cardiovascular trials encompassing 38 countries across 620 sites, including 3,400 patients, and other trials involving complex and rare diseases. Her responsibilities have spanned the full duration of studies, from start-up to project close-out and review.
Share Laurie’s expertise with your network & colleagues